Navigation Links
Arecor Appoints Dr. Sarah Howell as Chief Operating Officer
Date:11/10/2011

CAMBRIDGE, England, November 10, 2011 /PRNewswire/ --

Arecor, the leading company in advancing aqueous formulation solutions for proteins, peptides and vaccines, is pleased to announce the appointment of Dr Sarah Howell as Chief Operating Officer.  Dr Howell will be responsible for the operations of Arecor, with a focus on developing and maintaining Arecor's upward growth curve ensuring the company continues to deliver exceptional formulation solutions and performance to the highest standards across the industry.

Dr Howell has a strong background in clinical and commercial pharmaceutical product development, manufacture, supply and licensing across a range of products and therapeutic areas having worked in a number of leading roles in the pharmaceutical industry, most recently as Vice President for CMC (Chemistry, Manufacturing & Controls) and Technical Development for BTG where she had responsibility for CMC development and supply across BTG's diverse portfolio of products.  Previously she held senior roles in product development and manufacturing for UCB-Celltech and GlaxoSmithKline.  She is also an active member of the BioIndustry Association (BIA) Manufacturing Advisory Committee.  Dr Howell has an honours degree in Chemistry from the University of Birmingham and a PhD in Physical Organic Chemistry from the University of St Andrews.

Tom Saylor, CEO of Arecor stated "Sarah's considerable technical and leadership experience in the management of development programmes for biologic drugs, and her capabilities in building partnerships with major pharmaceutical companies will be a tremendous asset to Arecor as it expands its business in an industry looking to formulation as an enabling technology for the new generation of biologic drugs."

Arecor was established to provide formulation solutions to pharmaceutical and biotech companies developing proteins, vaccines and diagnostics based upon new insights into stabilization of biologics.  Proteins and vaccines are often fragile entities, and stability can represent significant constraints in the development of new products and extending the use of existing products.  Arecor has developed Arestat™, a patented set of tools for stabilization which address the main pathways of degradation.  As a simple reformulation, Arestat™ can be readily incorporated into standard manufacturing practice, without covalent modification of the biologic and using excipients approved for the route of delivery. Arecor currently has active feasibility programs and licenses with many of the top pharmaceutical and biotech companies on a wide range of proteins and vaccines.

Contact:

Tom Saylor, CEO tsaylor@arecor.com
Arecor Ltd
2 Cambridge Science Park
Cambridge, UK
http://www.arecor.com
+44(0)1223-426060



'/>"/>
SOURCE Arecor
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Saladax Biomedical, Inc. Appoints Li Zhang, M.D., to Scientific Advisory Board
2. NeuroCog Trials Appoints Industry Executive Michael Hufford, Ph.D. to Chief Operating Officer
3. Virobay Appoints David B. Karpf, M.D. as Chief Medicial Officer
4. Axia Value Chain Appoints John Christina Managing Director of Life Sciences Practice
5. Marshall Edwards Appoints Healthcare Investment Banking Veteran Charles Baltic to Board of Directors
6. Metabolex Appoints Raymond Urbanski M.D., Ph.D. to Position of Chief Medical Officer
7. Amgen Appoints Anthony (Tony) Hooper Executive Vice President Global Commercial Operations
8. Kessler Foundation Appoints New Director of Human Performance and Engineering Laboratory
9. China Botanic Appoints Zack Zibing Pan as an Independent Director and Chairman of its Audit Committee
10. Immune Design Corp. Appoints Guy F. Cipriani as Chief Business Officer
11. Amgen Appoints Robert A. Bradway to the Companys Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017 ... London (ICR) and University of ... prognostic tool to risk-stratify patients with multiple myeloma (MM), in ... nine . The University of Leeds ... by Myeloma UK, and ICR will perform the testing services ...
(Date:10/11/2017)... TX (PRWEB) , ... October 11, 2017 , ... ... August compared the implantation and pregnancy rates in frozen and fresh in ... contribution of progesterone and maternal age to IVF success. , After comparing the ...
(Date:10/10/2017)... ... ... San Diego-based team building and cooking events company, Lajollacooks4u, has unveiled a ... new look is part of a transformation to increase awareness, appeal to new markets ... It will also expand its service offering from its signature gourmet cooking classes and ...
(Date:10/10/2017)... (PRWEB) , ... October 10, 2017 , ... ... Science Center’s FirstHand program has won a US2020 STEM Mentoring Award. Representatives of ... award for Excellence in Volunteer Experience from US2020. , US2020’s mission is to ...
Breaking Biology Technology:
(Date:4/11/2017)... , April 11, 2017 NXT-ID, ... security technology company, announces the appointment of independent Directors Mr. ... to its Board of Directors, furthering the company,s corporate ... ... NXT-ID, we look forward to their guidance and benefiting from ...
(Date:4/5/2017)... 2017 KEY FINDINGS The global ... a CAGR of 25.76% during the forecast period of ... factor for the growth of the stem cell market. ... MARKET INSIGHTS The global stem cell market is ... geography. The stem cell market of the product is ...
(Date:3/30/2017)... The research team of The Hong Kong Polytechnic University (PolyU) ... ground breaking 3D fingerprint minutiae recovery and matching technology, pushing contactless ... use in identification, crime investigation, immigration control, security of access and ... ... A research team led by Dr Ajay Kumar ...
Breaking Biology News(10 mins):